The copy number amplification coincided with higher MECOM expression in patients of ovarian cancer compared to healthy controls as analysed by pan-cancer microarray datasets HG-U133 microarray (GPL570 platform) [38] (Supplementary Fig. 1B). Here, MECOM is linked to ovarian cancer.